Porton Advanced’s Comprehensive CDMO Solutions Facilitates Qihan Biotech with FDA Clearance of IND application of its First-in-Class Universal Dual-Targeting CAR-T Cell Therapy
Porton Advanced and CellStore Partner to Optimize Cryopreservation Media for More Affordable Cell Therapies
Porton Advanced and EVA Pharma Sign MOU to Expand CAR T-Cell Therapy Access in The Middle East and Africa
Porton Advanced Announces Collaboration with TongEYE to Accelerate Development of iPSC-RPEC transplantation therapy
Porton Advanced Announces Collaboration with Hualong Biological to Accelerate MATC Cell Therapy Development for Solid Tumor Treatment Breakthroughs
Safety and Transduction Efficiency of Lentivirus Helper Plasmids
